AtriCure | 营业费用



金融业
股票价格
USD
资产
USD 654.18M
现金及等价物
USD 167.43M
销售成本
USD 35.16M
流动资产
USD 322.52M
流动负债
USD 81.52M
债务
USD 76.73M
股息收益率
0
EBIT
USD 2.49M
EBITDA
USD 19.86M
员工
1.3K
EPS每股收益
USD 0.06
股本和储备
USD 491.94M
销售毛利
USD 105.34M
债务利息支出
USD 1.33M
利息收入
USD 1.17M
贷款资金
USD 61.87M
市值
USD 1.51B
净收入
USD 1.76M
营业费用
USD 138.01M
营业利润
USD 2.49M
普通股股本
USD 49.7M
PE价格收益
USD 34.15
税前利润
USD 2.36M
销售收入
USD 140.5M
销售和管理费用
USD 78.34M
股票
USD 78.49M
贸易债权人
USD 78.4M
应收帐款人
USD 66.65M


营业费用 更改 日
Abbott USD 9.21B 17M 2025-12
Artivion USD 56.62M 195K 2024-09
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 924.8M 40.2M 2025-09
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
J&J USD 18.97B 2.38B 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
ResMed USD 925.21M 51.98M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12


AtriCure 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.